ImmunoGen
IMGN
#2211
Rank
NZ$15.54 B
Marketcap
NZ$55.65
Share price
0.00%
Change (1 day)
138.74%
Change (1 year)

ImmunoGen (IMGN) - Total assets

Total assets on the balance sheet as of September 2023 : NZ$1.46 Billion

According to ImmunoGen 's latest financial reports the company's total assets are NZ$1.46 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

ImmunoGen - Total assets on balance sheet (from 2001 to 2023)

Total assets by year

Year Total assets Change
2022-12-31NZ$0.54 B-28.6%
2021-12-31NZ$0.76 B56.42%
2020-12-31NZ$0.49 B40.87%
2019-12-31NZ$0.34 B-20.67%
2018-12-31NZ$0.44 B6.13%
2017-12-31NZ$0.41 B
2016-06-30NZ$0.39 B-13.84%
2015-06-30NZ$0.45 B140.74%
2014-06-30NZ$0.18 B-31.66%
2013-06-30NZ$0.27 B22.86%
2012-06-30NZ$0.22 B-14.48%
2011-06-30NZ$0.26 B32.45%
2010-06-30NZ$0.19 B26.28%
2009-06-30NZ$0.15 B43.39%
2008-06-30NZ$0.10 B4.72%
2007-06-30NZ$0.10 B-32.69%
2006-06-30NZ$0.15 B-3.48%
2005-06-30NZ$0.16 B-16.02%
2004-06-30NZ$0.19 B-5.43%
2003-06-30NZ$0.20 B-35.24%
2002-06-30NZ$0.31 B-20.03%
2001-06-30NZ$0.39 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
NZ$358.27 B 24,356.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$217.45 B 14,744.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$358.39 B 24,365.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$253.53 B 17,207.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$170.41 B 11,533.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$262.47 B 17,817.51%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$156.15 B 10,559.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
NZ$6.47 B 342.07%๐Ÿ‡บ๐Ÿ‡ธ USA